Synthetic RNA circuits

Nature Chemical Biology

Volumn 3, Issue 1, 2007, Pages 23-28

  Davidson, Eric A ^a   Ellington, Andrew D ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; COCARBOXYLASE; COMPLEMENTARY RNA; DEOXYRIBOZYME; MESSENGER RNA; MICRORNA; NUCLEIC ACID; NUCLEOTIDE; RIBOZYME; RNA; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; SMALL NUCLEOLAR RNA; VIRUS PROTEIN;

3' UNTRANSLATED REGION; CELL TRANSPORT; DNA BINDING; GENE CONTROL; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; RNA ANALYSIS; RNA BINDING; RNA HYBRIDIZATION; RNA SEQUENCE; RNA STRUCTURE; RNA SYNTHESIS; RNA TRANSPORT; STRUCTURE ANALYSIS; TRANSCRIPTION REGULATION; VIRUS SURVIVAL;

EID: 33845735891     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio846     Document Type: Review

References (82)

1. Blencowe, B.J. Alternative splicing: new insights from global analyses. Cell 126, 37-47 (2006).
2. Henkin, T.M. & Yanofsky, C. Regulation by transcription attenuation in bacteria: how RNA provides instructions for transcription termination/antitermination decisions. Bioessays 24, 700-707 (2002).
3. Keene, J.D. Ribonucleoprotein infrastructure regulating the flow of genetic information between the genome and the proteome. Proc. Natl. Acad. Sci. USA 98, 7018-7024 (2001).
4. Lewis, B.P., Burge, C.B. & Bartel, D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20 (2005).
5. Gilbert, W. Origin of life: the RNA world. Nature 319, 618 (1986).
6. Clop, A. et al. A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat. Genet. 38, 813-818 (2006).
7. Bartel, D.P. & Chen, C.Z. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat. Rev. Genet. 5, 396-400 (2004).
8. Hornstein, E. & Shomron, N. Canalization of development by microRNAs. Nat. Genet. 38 (suppl.), 20-24 (2006).
9. Inouye, M. Antisense RNA: its functions and applications in gene regulation-a review. Gene 72, 25-34 (1988).
10. Fichou, Y. & Ferec, C. The potential of oligonucleotides for therapeutic applications. Trends Biotechnol. 24, 563-570 (2006).
11. Dykxhoorn, D.M., Palliser, D. & Lieberman, J. The silent treatment: siRNAs as small molecule drugs. Gene Ther. 13, 541-552 (2006).
12. Cullen, B.R. Transcription and processing of human microRNA precursors. Mol. Cell 16, 861-865 (2004).
13. Wassarman, K.M. & Storz, G. 6S RNA regulates E. coli RNA polymerase activity. Cell 101, 613-623 (2000).
14. Allen, T.A., Von Kaenel, S., Goodrich, J.A. & Kugel, J.F. The SINE-encoded mouse B2 RNA represses mRNA transcription in response to heat shock. Nat. Struct. Mol. Biol. 11, 816-821 (2004).
15. Espinoza, C.A., Allen, T.A., Hieb, A.R., Kugel, J.F. & Goodrich, J.A. B2 RNA binds directly to RNA polymerase II to repress transcript synthesis. Nat. Struct. Mol. Biol. 11, 822-829 (2004).
16. Thomas, M. et al. Selective targeting and inhibition of yeast RNA polymerase II by RNA aptamers. J. Biol. Chem. 272, 27980-27986 (1997).
17. Kettenberger, H. et al. Structure of an RNA polymerase II-RNA inhibitor complex elucidates transcription regulation by noncoding RNAs. Nat. Struct. Mol. Biol. 13, 44-48 (2006).
18. Held, D.M., Kissel, J.D., Patterson, J.T., Nickens, D.G. & Burke, D.H. HIV-1 inactivation by nucleic acid aptamers. Front. Biosci. 11, 89-112 (2006).
19. Yan, A.C., Bell, K.M., Breeden, M.M. & Ellington, A.D. Aptamers: prospects in therapeutics and biomedicine. Front. Biosci. 10, 1802-1827 (2005).
20. Joshi, P.J., Fisher, T.S. & Prasad, V.R. Anti-HIV inhibitors based on nucleic acids: emergence of aptamers as potent antivirals. Curr. Drug Targets Infect. Disord. 3, 383-400 (2003).
21. Cho, E.J., Rajendran, M. & Ellington, A.D. in Advanced Concepts in Fluorescence Spectroscopy; Macromolecular Sensing (eds. Geddes, C.D. & Lakowicz, J.R.) 127-155 (Springer, Baltimore, 2005).
22. Knudsen, S.M. & Ellington, A.D. Ribozyme deja vu. Nat. Struct. Mol. Biol. 11, 301-303 (2004).
23. Winkler, W., Nahvi, A. & Breaker, R.R. Thiamine derivatives bind messenger RNAs directly to regulate bacterial gene expression. Nature 419, 952-956 (2002).
24. Mironov, A.S. et al. Sensing small molecules by nascent RNA: a mechanism to control transcription in bacteria. Cell 111, 747-756 (2002).
25. Thore, S., Leibundgut, M. & Ban, N. Structure of the eukaryotic thiamine pyrophosphate riboswitch with its regulatory ligand. Science 312, 1208-1211 (2006).
26. Serganov, A., Polonskaia, A., Phan, A.T., Breaker, R.R. & Patel, D.J. Structural basis for gene regulation by a thiamine pyrophosphate-sensing riboswitch. Nature 441, 1167-1171 (2006).
27. Sudarsan, N. et al. Tandem riboswitch architectures exhibit complex gene control functions. Science 314, 300-304 (2006).
28. Mandal, M. et al. A glycine-dependent riboswitch that uses cooperative binding to control gene expression. Science 306, 275-279 (2004).
29. Winkler, W.C. & Breaker, R.R. Regulation of bacterial gene expression by riboswitches. Annu. Rev. Microbiol. 59, 487-517 (2005).
30. Sudarsan, N., Barrick, J.E. & Breaker, R.R. Metabolite-binding RNA domains are present in the genes of eukaryotes. RNA 9, 644-647 (2003).
31. Kubodera, T. et al. Thiamine-regulated gene expression of Aspergillus oryzae thiA requires splicing of the intron containing a riboswitch-like domain in the 5′-UTR. FEBS Lett. 555, 516-520 (2003).
32. Doudna, J.A. & Lorsch, J.R. Ribozyme catalysis: not different, just worse. Nat. Struct. Mol. Biol. 12, 395-402 (2005).
33. Winkler, W.C., Nahvi, A., Roth, A., Collins, J.A. & Breaker, R.R. Control of gene expression by a natural metabolite-responsive ribozyme. Nature 428, 281-286 (2004).
34. Teixeira, A. et al. Autocatalytic RNA cleavage in the human beta-globin pre-mRNA promotes transcription termination. Nature 432, 526-530 (2004).
35. Salehi-Ashtiani, K., Luptak, A., Litovchick, A. & Szostak, J.W. A genomewide search for ribozymes reveals an HDV-like sequence in the human CPEB3 gene. Science 313, 1788-1792 (2006).
36. Przybilski, R. et al. Functional hammerhead ribozymes naturally encoded in the genome of Arabidopsis thaliana. Plant Cell 17, 1877-1885 (2005).
37. Fiammengo, R. & Jaschke, A. Nucleic acid enzymes. Curr. Opin. Biotechnol. 16, 614-621 (2005).
38. Soukup, G.A. & Breaker, R.R. Engineering precision RNA molecular switches. Proc. Natl. Acad. Sci. USA 96, 3584-3589 (1999).
39. Robertson, M.P. & Ellington, A.D. In vitro selection of an allosteric ribozyme that transduces analytes to amplicons. Nat. Biotechnol. 17, 62-66 (1999).
40. Robertson, M.P. & Ellington, A.D. In vitro selection of nucleoprotein enzymes. Nat. Biotechnol. 19, 650-655 (2001).
41. Vaish, N.K. et al. Monitoring post-translational modification of proteins with allosteric ribozymes. Nat. Biotechnol. 20, 810-815 (2002).
42. Atsumi, S., Ikawa, Y., Shiraishi, H. & Inoue, T. Design and development of a catalytic ribonucleoprotein. EMBO J. 20, 5453-5460 (2001).
43. Hartig, J.S. et al. Protein-dependent ribozymes report molecular interactions in real time. Nat. Biotechnol. 20, 717-722 (2002).
44. Robertson, M.P., Knudsen, S.M. & Ellington, A.D. In vitro selection of ribozymes dependent on peptides for activity. RNA 10, 114-127 (2004).
45. Najafi-Shoushtari, S.H., Mayer, G. & Famulok, M. Sensing complex regulatory networks by conformationally controlled hairpin ribozymes. Nucleic Acids Res. 32, 3212-3219 (2004).
46. Breaker, R.R. Engineered allosteric ribozymes as biosensor components. Curr. Opin. Biotechnol. 13, 31-39 (2002).
47. Wu, A.M. & Senter, P.D. Arming antibodies: prospects and challenges for immunoconjugates. Nat. Biotechnol. 23, 1137-1146 (2005).
48. Homann, M. & Goringer, H.U. Combinatorial selection of high affinity RNA ligands to live African trypanosomes. Nucleic Acids Res. 27, 2006-2014 (1999).
49. Shangguan, D. et al. Aptamers evolved from live cells as effective molecular probes for cancer study. Proc. Natl. Acad. Sci. USA 103, 11838-11843 (2006).
50. Lupold, S.E., Hicke, B.J., Lin, Y. & Coffey, D.S. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res. 62, 4029-4033 (2002).
51. Chu, T.C. et al. Aptamer:toxin conjugates that specifically target prostate tumor cells. Cancer Res. 66, 5989-5992 (2006).
52. Farokhzad, O.C. et al. Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res. 64, 7668-7672 (2004).
53. Farokhzad, O.C. et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc. Natl. Acad. Sci. USA 103, 6315-6320 (2006).
54. Chu, T.C., Twu, K.Y., Ellington, A.D. & Levy, M. Aptamer mediated siRNA delivery. Nucleic Acids Res. 34, e73 (2006).
55. McNamara, J.O., II et al. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat. Biotechnol. 24, 1005-1015 (2006).
56. Werstuck, G. & Green, M.R. Controlling gene expression in living cells through small molecule-RNA interactions. Science 282, 296-298 (1998).
57. Grate, D. & Wilson, C. Inducible regulation of the S. cerevisiae cell cycle mediated by an RNA aptamer-ligand complex. Bioorg. Med. Chem. 9, 2565-2570 (2001).
58. Harvey, I., Garneau, P. & Pelletier, J. Inhibition of translation by RNA-small molecule interactions. RNA 8, 452-463 (2002).
59. Hanson, S., Bauer, G., Fink, B. & Suess, B. Molecular analysis of a synthetic tetracycline-binding riboswitch. RNA 11, 503-511 (2005).
60. Suess, B. et al. Conditional gene expression by controlling translation with tetracycline-binding aptamers. Nucleic Acids Res. 31, 1853-1858 (2003).
61. Hanson, S., Berthelot, K., Fink, B., McCarthy, J.E. & Suess, B. Tetracycline-aptamer-mediated translational regulation in yeast. Mol. Microbiol. 49, 1627-1637 (2003).
62. Kim, D.S., Gusti, V., Pillai, S.G. & Gaur, R.K. An artificial riboswitch for controlling pre-mRNA splicing. RNA 11, 1667-1677 (2005).
63. Suess, B., Fink, B., Berens, C., Stentz, R. & Hillen, W. A theophylline responsive riboswitch based on helix slipping controls gene expression in vivo. Nucleic Acids Res. 32, 1610-1614 (2004).
64. Desai, S.K. & Gallivan, J.P. Genetic screens and selections for small molecules based on a synthetic riboswitch that activates protein translation. J. Am. Chem. Soc. 126, 13247-13254 (2004).
65. Kertsburg, A. & Soukup, G.A. A versatile communication module for controlling RNA folding and catalysis. Nucleic Acids Res. 30, 4599-4606 (2002).
66. Thompson, K.M., Syrett, H.A., Knudsen, S.M. & Ellington, A.D. Group I aptazymes as genetic regulatory switches. BMC Biotechnol. [online] 2, 21 (2002).
67. Yen, L. et al. Exogenous control of mammalian gene expression through modulation of RNA self-cleavage. Nature 431, 471-476 (2004).
68. Yen, L., Magnier, M., Weissleder, R., Stockwell, B.R. & Mulligan, R.C. Identification of inhibitors of ribozyme self-cleavage in mammalian cells via high-throughput screening of chemical libraries. RNA 12, 797-806 (2006).
69. Isaacs, F.J. et al. Engineered riboregulators enable post-transcriptional control of gene expression. Nat. Biotechnol. 22, 841-847 (2004).
70. Lease, R.A., Cusick, M.E. & Belfort, M. Riboregulation in Escherichia coli: DsrA RNA acts by RNA:RNA interactions at multiple loci. Proc. Natl. Acad. Sci. USA 95, 12456-12461 (1998).
71. Bayer, T.S. & Smolke, C.D. Programmable ligand-controlled riboregulators of eukaryotic gene expression. Nat. Biotechnol. 23, 337-343 (2005).
72. An, C.I., Trinh, V.B. & Yokobayashi, Y. Artificial control of gene expression in mammalian cells by modulating RNA interference through aptamer-small molecule interaction. RNA 12, 710-716 (2006).
73. SenGupta, D.J. et al. A three-hybrid system to detect RNA-protein interactions in vivo. Proc. Natl. Acad. Sci. USA 93, 8496-8501 (1996).
74. Sengupta, D.J., Wickens, M. & Fields, S. Identification of RNAs that bind to a specific protein using the yeast three-hybrid system. RNA 5, 596-601 (1999).
75. Saha, S., Ansari, A.Z., Jarrell, K.A. & Ptashne, M. RNA sequences that work as transcriptional activating regions. Nucleic Acids Res. 31, 1565-1570 (2003).
76. Buskirk, A.R., Kehayova, P.D., Landrigan, A. & Liu, D.R. In vivo evolution of an RNA-based transcriptional activator. Chem. Biol. 10, 533-540 (2003).
77. Buskirk, A.R., Landrigan, A. & Liu, D.R. Engineering a ligand-dependent RNA transcriptional activator. Chem. Biol. 11, 1157-1163 (2004).
78. Elowitz, M.B. & Leibler, S. A synthetic oscillatory network of transcriptional regulators. Nature 403, 335-338 (2000).
79. Gardner, T.S., Cantor, C.R. & Collins, J.J. Construction of a genetic toggle switch in Escherichia coli. Nature 403, 339-342 (2000).
80. Levskaya, A. et al. Synthetic biology: engineering Escherichia coli to see light. Nature 438, 441-442 (2005).
81. Benenson, Y., Gil, B., Ben-Dor, U., Adar, R. & Shapiro, E. An autonomous molecular computer for logical control of gene expression. Nature 429, 423-429 (2004).
82. Stojanovic, M.N. & Stefanovic, D. A deoxyribozyme-based molecular automaton. Nat. Biotechnol. 21, 1069-1074 (2003).